• FDA Approves EYLEA® americanpharmaceuticalreview
    May 15, 2019
    Regeneron has announced the U.S. Food and Drug Administration (FDA) has approved EYLEA® (aflibercept) Injection to treat all stages of diabetic retinopathy (DR) which helps to reduce the risk of blindness.
PharmaSources Customer Service